Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,483.0
10.7 (0.43%)

 

  • STI Straits Times Index
    2,483.0
    10.7 (0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,511.7
    2.5 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,476.0
    240.6 (1.04%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,217.5
    -1.9 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,511.6
    307.0 (1.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,906.5
    -39.2 (-0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 764.8M
  • Value: 848.5M
  • Rise: 135
  • Fall: 143
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.053+0.002
Vicplas Intl0.355-0.095
Sembcorp Marine0.143+0.001
OEL0.019+0.001
Singtel2.120-0.020
Synagie0.200-0.010
HPH Trust USD0.136+0.006
Oceanus^0.007-
QT Vascular0.007-
ThaiBev0.595+0.010

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EBOS GROUP EBOS GROUP
Updated on 28 Sep 2020 (End of trading day)
Last (AUD): 22.020 Change: +0.170 High: 22.030 Remarks: -
Change (%): +0.78 Low: 22.020
Open 22.030 Yesterday's Close 21.849999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 504 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a 0.99777 Trailing EPS (AUD) e 0.99777 NAV (AUD) b 8.0730
PE a 22.069 Trailing PE f 22.069 Price / NAV b 2.7276
Dividend (AUD) d 0.767527 Cash In Hand (AUD) g 1.5028 Issued & Paid-up Shares c 162,882,000
Dividend Yield (%) d 3.486 Price / Cash In Hand g 14.653 Treasury Shares h -
Beta - 75 Daysi -0.042 R-Squared - 75 Days(%)i 0.03 Market Cap (M) 3,586.662
Beta - 500 Daysi 0.203 R-Squared - 500 Days (%)i 0.67 Enterprise Value (M) 4,146.794
Piotroski F Score 5 Exchange Code EBO Par Value ( NZD ) n.a.
52 Weeks Volatility (%) 26.97 Free Float (%) 79.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Aug 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EBOS GROUP ASX 3,586.662 22.069 22.069 2.7276 3.486
Industry Medical Specialties ASX 1,941.551 90.404 90.627 9.8458 0.707
Local Peer FISHER & PAYKEL HEALTHCARE CORP ASX 17,773.708 65.109 65.108 18.8427 0.993
Local Peer COCHLEAR LTD ASX 13,165.883 - - 9.3942 -
Local Peer NANOSONICS LIMITED ASX 1,741.783 171.810 171.824 14.0194 -
Local Peer MCP INCOME OPPORTUNITIES TRUST ASX 555.056 - - -388.7755 -
Local Peer AROA BIOSURGERY LTD ASX 405.101 - - 54.8780 -
Local Peer MEDICAL DEVELOPMENT INTL ASX 328.118 865.052 865.745 7.5712 -
Local Peer VOLPARA HEALTH TECHNOLOGIES LTD ASX 329.827 - - 6.5196 -
Local Peer ATOMO DIAGNOSTICS LIMITED ASX 205.257 - - - -
Local Peer SOMNOMED LIMITED ASX 194.484 - - 5.7485 -
Local Peer CYCLOPHARM LIMITED ASX 180.618 - - 10.6282 0.433
Local Peer EMVISION MEDICAL DEVICES LTD ASX 183.256 - - 33.1639 -
Local Peer RESPIRI LTD ASX 153.417 - - 61.8421 -
Other Local Peers SDI LTD (ASX), RESAPP HEALTH LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), COMPUMEDICS (ASX), MICRO-X LTD (ASX), IMPEDIMED LIMITED (ASX), OPTISCAN IMAGING (ASX), RESONANCE HEALTH LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), INCANNEX HEALTHCARE LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), CARDIEX LTD (ASX), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), METALICITY LIMITED (ASX), USCOM LTD (ASX), ADHERIUM LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ANALYTICA (ASX), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGARD LIMITED (ASX)
Global Peer ABBOTT LABORATORIES NYSE 183,161.329 49.962 59.603 5.9900 1.270
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 167,053.279 45.198 45.076 5.5917 0.181
Global Peer DANAHER CORP NYSE 146,961.168 59.049 50.310 4.4542 0.322
Global Peer MEDTRONIC PLC NYSE 138,669.735 28.956 31.430 2.7571 2.089
Global Peer INTUITIVE SURGICAL INC NASDAQ 78,843.927 57.162 69.405 9.0205 -
Global Peer STRYKER CORP NYSE 77,002.986 36.967 48.097 6.0376 1.038
Global Peer BECTON DICKINSON & CO NYSE 64,953.846 60.031 83.920 2.7042 1.282
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,421.218 11.366 13.422 3.4209 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,153.840 45.997 64.758 12.5429 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,070.269 31.443 36.861 3.3388 2.029
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALCON AG (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TOPGLOV (Bursa), Top Glove (SGX), HOLOGIC INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), HARTA (Bursa), STERIS PLC (NYSE), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), WATERS CORP (NYSE), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), PENUMBRA INC (NYSE), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), OUTSET MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), CIRC (HKEx), ATRION CORP (NASDAQ), LIFETECH SCI (HKEx), CERUS CORP (NASDAQ), KDL MEDICAL (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CRYOLIFE INC (NYSE), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SI BONE INC (NASDAQ), VAPOTHERM INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), Medtecs Intl (SGX), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), UG Healthcare (SGX), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), GOLDEN MEDITECH (HKEx), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), REPRO MEDSYSTEMS INC (NASDAQ), PW MEDTECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), TELA BIO INC (NASDAQ), ALPHA PRO TECH (NYSE American), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DARIOHEALTH CORP (NASDAQ), LKL (Bursa), VINCENT MED (HKEx), INTRICOM CORP (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROMED INC (NYSE American), NEURONETICS INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), ELECTROCORE INC (NASDAQ), YUNNAN ENERGY (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), Biolidics (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), KELFRED (HKEx), SENSUS HEALTHCARE INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), Yunnan Energy (SGX), MOTUS GI HOLDINGS INC (NASDAQ), LIFE HEALTHCARE (HKEx), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), BIOLASE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), Annica (SGX), DIGIRAD CORP (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), STHAI (SET), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.180
-0.81 %
10 Days --0.340
-1.52 %
20 Days -+1.020
+4.86 %
Medium Term Return 3 Months -+1.820
+9.01 %
6 Months -+0.920
+4.36 %
1 Year --0.960
-4.18 %
Long Term Return 2 Years -+1.210
+5.81 %
3 Years -+6.170
+38.93 %
5 Years -+10.660
+93.84 %
Annualised Return Annualised --
+14.15 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 18.800 - 24.250 Change From 1 Year Low +3.220 % Change From 1 Year Low (%) +17.13
Change From 1 Year High -2.230 % Change From 1 Year High (%) -9.20
2 Years Range 18.750 - 24.500 Change From 2 Years Low +3.270 % Change From 2 Years Low (%) +17.44
Change From 2 Years High -2.480 % Change From 2 Years High (%) -10.12
5 Years Range 11.360 - 24.500 Change From 5 Years Low +10.660 % Change From 5 Years Low (%) +93.84
Change From 5 Years High -2.480 % Change From 5 Years High (%) -10.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. It operates through the following segments: Healthcare, Animal Care, and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, own brands, retail healthcare, wholesale activities. The Animal Care segment sells animal care products in a range of sectors, own brands, retail and wholesale activities. The Corporate segment includes net funding costs and central administration expenses. The company was founded on September 11, 1922 and is headquartered in Christchurch, New Zealand.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Sep 2020 22.030 22.030 22.020 22.020 504 -
25 Sep 2020 22.010 22.100 21.400 21.850 23,812 -
24 Sep 2020 22.210 22.210 21.950 22.000 8,396 -
23 Sep 2020 22.600 22.600 22.160 22.250 40,213 -
22 Sep 2020 22.210 22.550 22.050 22.050 2,041 -
21 Sep 2020 22.510 22.550 22.000 22.200 1,525 -
18 Sep 2020 22.760 22.760 22.500 22.500 16,813 -
17 Sep 2020 22.460 22.900 22.460 22.750 4,148 -
16 Sep 2020 22.320 22.440 22.100 22.440 2,172 -
15 Sep 2020 22.350 22.450 22.010 22.310 5,378 -
14 Sep 2020 22.280 22.370 22.280 22.360 2,518 -
11 Sep 2020 22.190 22.200 21.990 22.150 4,129 -
10 Sep 2020 22.300 22.380 22.150 22.290 689 -
09 Sep 2020 22.160 22.240 22.110 22.140 3,561 -
08 Sep 2020 21.840 22.230 21.790 22.230 3,250 -
07 Sep 2020 22.010 22.290 21.800 22.090 4,642 -
04 Sep 2020 22.310 22.470 21.800 22.250 5,152 -
03 Sep 2020 22.490 23.000 22.090 23.000 9,076 -
02 Sep 2020 22.060 22.220 21.990 22.070 6,987 -
01 Sep 2020 21.500 21.690 21.310 21.380 13,066 -
31 Aug 2020 21.750 21.810 21.000 21.000 18,174 -
28 Aug 2020 20.630 21.100 20.630 20.910 41,281 -
Summary
Current 2 Weeks
(15 Sep 2020 to 28 Sep 2020)
22.350 22.900 21.400 22.020 105,002 -
Previous 2 Weeks
(01 Sep 2020 to 14 Sep 2020)
21.500 22.900 21.310 22.360 53,070 -
4 Weeks from
(04 Aug 2020 to 31 Aug 2020)
20.320 22.900 20.100 21.000 298,895 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.